Deep learning radiomics models based on CT or PET/CT have been shown to infer PD-L1 status in a non-invasive manner, and predict durable benefit from immunotherapy in advanced NSCLC, thus supporting treatment decision-making tissues are limited or repeated biopsies are impractical (201). The gene discussed is CD274; the disease is non-small cell lung carcinoma.